Premium Access: Available NOW Member Access: Available NOW Public Access: Available NOW
THE 3 MINUTE PRESS SHOW with Tracee Tolentino
Discover the News behind the News from today's leading executives. Each day we interview the leading Executives on the press of that day.
The 3 Minute Press Show gives you the:
Who, What, Where, When, Why and How of this Press and how it will impact the company and its shareholders.
Members are encouraged to ask these executives questions through their message boards at Mywallst
SinoFresh HealthCare, Inc. is a developer and marketer of innovative upper
respiratory system therapies. The company is researching broad-spectrum
antiseptic approaches to reducing viral, bacterial and fungal organisms that
are suspected to cause pathogenesis of the mouth, nose and throat. The
company's lead product, SinoFresh(r) Nasal and Sinus Care, is a hygienic
cleansing spray that kills germs and removes other nasal-sinus irritants.
The company is also researching how antiseptic cleansing may alleviate
chronic sinus distress, a condition that may affect 37 million Americans
annually. SinoFresh(r) products are available in major retail outlets
nationwide. More information is available at http://www.sinofresh.com.
http://www.thewest.com.au/default.aspx?MenuID=32&ContentID=116277
‘Net gossip’ hurts CityView: chief
6th January 2009, 8:00 WST
CityView Corp chief Mark Smyth has criticised what he calls “unsubstantiated gossip” on the internet for exacerbating the oil minnow’s woes as he prepares to face a push by shareholders to oust him at an extraordinary general meeting later this month.
Speaking via webcast in a Boardroomradio interview released to the Australian Securities Exchange yesterday, Mr Smyth hit out at those shareholders who, he said, wanted to blame “everyone except themselves” for the company’s performance.
“Shareholders are upset because the CityView share price is so low - indeed we are all concerned about this,” he said.
“The reality is that all resource stocks worldwide have been affected by the crash and CityView is no exception.
“The situation is exacerbated by the negative chatter and unsubstantiated gossip on the internet, creating general confusion and uncertainty. Some of these groups mean well but others blame everyone except themselves for the current predicament.”
A group of shareholders, believed to represent about 11 per cent of CityView shares, requisitioned a meeting last month to have Mr Smyth removed from the board but remain in his role as chief executive.
Citing concerns about the company’s management, cash burn and the terms of a rights issue last year, they want, among other things, four new directors appointed to the board, including dissenting shareholders Susan Turner and Steven Coughlan, and for the company to formally outline its six-month strategy.
Much of the dispute has been played out on popular share market gossip website HotCopper, where support for the extraordinary meeting was originally generated. The resolutions will be put to shareholders on January 30.
Shares in CityView have fallen 95 per cent in the past 12 months, from 28 cents in January 2008 to 1.4 cents yesterday.
At 12.25pm today, shares in the company were unchanged after sinking to 1.3 cents earlier in the day.
By comparison the market’s key S&P-ASX 200 index is down 41.5 per cent, although many explorers have been hit harder than the wider market.
The group was also affected by several board resignations last year.
The one-time technology investment group was reborn in 2006 as an energy explorer focused on Angola and the west coast of Africa.
Commenting on calls by shareholders for greater disclosure about how CityView’s money has been spent, Mr Smyth said it was already hard to conduct business in Angola and would be even harder if rival players were given access to sensitive information.
KATE EMERY
Teradata Corporation is the world's largest company solely focused on raising intelligence through data warehousing, consulting services and enterprise analytics. Teradata is in more than 60 countries...
Starwood Hotels & Resorts Worldwide, Inc., together with its subsidiaries, operates as a hotel and leisure company worldwide. It primarily operates luxury and upscale full service hotels, retreats, an...
GeneThera, Inc., a development stage biotechnology company, develops molecular assays for the detection of food contaminating pathogens, veterinary diseases, and genetically modified organisms. The co...
Vein Clinics of America, a wholly owned subsidiary of IntegraMed America, Inc.,
Horizon Air, an Alaska Air Group, Inc. company,
Ingen Technologies, Inc.